Insider Transactions in Q1 2024 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 18
2024
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.15%
|
$50,000
$10.29 P/Share
|
Jan 03
2024
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+8.02%
|
-
|
Jan 03
2024
|
Enrique Poradosu Chief Science & Business Off |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+7.96%
|
-
|